Status:

COMPLETED

Antaitavir Hasophate Capsules Combined With Yiqibuvir Tablets in Treatment Adult Patients With Chronic Hepatitis C

Lead Sponsor:

Sunshine Lake Pharma Co., Ltd.

Conditions:

Chronic HCV Infection

Eligibility:

All Genders

18+ years

Phase:

PHASE2

PHASE3

Brief Summary

The safety, tolerability and antiviral activity of Antaitavir Hasophate in Combination With Yiqibuvir in treatment-naive and treatment-experienced patients with chronic hepatitis C virus (HCV) infecti...

Detailed Description

Phase II: Exploring the efficacy and safety of different doses of Antaitavir Hasophate combined with fixed-dose Yiqibuvir in the treatment of adult patients with chronic hepatitis C for 12 weeks, prov...

Eligibility Criteria

Inclusion

  • Willing and able to provide written informed consent;
  • Male or female, age≥18 years;
  • Body mass index (BMI)≥18.0 and≤32.0 kg/m2, and Weight≥40 kg;
  • Serological detection of anti-HCV antibodies was positive at screening;
  • HCV RNA≥1×104 IU/mL at Screening;
  • HCV genotype 1\~6, mixed genotype or indeterminate assessed at Screening by the Central Laboratory.

Exclusion

  • Clinical hepatic decompensation (i.e., ascites, encephalopathy or variceal hemorrhage);
  • Chronic liver disease of a non-HCV etiology (Including but not limited to hemochromatosis, Wilson's disease,alfa-1 antitrypsin deficiency);
  • Significant cardiac disease(Including but not limited to myocardial infarction, bradycardia) ;
  • Psychiatric illness or psychological disease or relevant medical history;
  • Solid organ transplantation;
  • Subjects have any other medical disorder that may interfere with subjects treatment, assessment or compliance with the protocol.

Key Trial Info

Start Date :

June 21 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 11 2023

Estimated Enrollment :

514 Patients enrolled

Trial Details

Trial ID

NCT05395416

Start Date

June 21 2021

End Date

April 11 2023

Last Update

May 14 2025

Active Locations (36)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 9 (36 locations)

1

The First Affiliated Hospital of Bengbu Medical College

Bengbu, Anhui, China

2

The Second Hospital of Anhui Medical University

Hefei, Anhui, China

3

Anhui Provincial Hospital

Hefei, Anwei, China

4

Peking University People's Hospital

Beijing, Beijing Municipality, China, 100044